| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 11 | 2021 | 278 | 4.840 |
Why?
|
| Exosomes | 8 | 2021 | 86 | 3.960 |
Why?
|
| Breast Neoplasms | 8 | 2019 | 441 | 2.980 |
Why?
|
| Docosahexaenoic Acids | 7 | 2015 | 87 | 2.240 |
Why?
|
| Clioquinol | 7 | 2011 | 11 | 1.950 |
Why?
|
| Neoplasms | 9 | 2020 | 748 | 1.950 |
Why?
|
| Cell Line, Tumor | 22 | 2021 | 1259 | 1.850 |
Why?
|
| Signal Transduction | 7 | 2019 | 1333 | 1.590 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2019 | 439 | 1.460 |
Why?
|
| Extracellular Vesicles | 2 | 2021 | 29 | 1.460 |
Why?
|
| Zinc | 6 | 2014 | 52 | 1.290 |
Why?
|
| Antineoplastic Agents | 6 | 2011 | 655 | 1.240 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2018 | 9 | 1.230 |
Why?
|
| Biomarkers, Tumor | 4 | 2019 | 376 | 1.200 |
Why?
|
| Superoxide Dismutase | 5 | 2015 | 68 | 1.170 |
Why?
|
| PPAR alpha | 3 | 2012 | 31 | 1.060 |
Why?
|
| Protoporphyrins | 2 | 2015 | 11 | 0.940 |
Why?
|
| beta Catenin | 2 | 2015 | 62 | 0.910 |
Why?
|
| Pancreatic Neoplasms | 4 | 2021 | 505 | 0.900 |
Why?
|
| Proteolysis | 2 | 2015 | 55 | 0.900 |
Why?
|
| Lysosomes | 3 | 2015 | 54 | 0.890 |
Why?
|
| Heme Oxygenase-1 | 2 | 2014 | 36 | 0.880 |
Why?
|
| Humans | 35 | 2021 | 26799 | 0.830 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2020 | 5 | 0.730 |
Why?
|
| Proteasome Inhibitors | 3 | 2015 | 24 | 0.690 |
Why?
|
| Apoptosis | 5 | 2010 | 737 | 0.680 |
Why?
|
| Drug Carriers | 1 | 2020 | 109 | 0.670 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 122 | 0.660 |
Why?
|
| Histone Deacetylases | 1 | 2019 | 22 | 0.650 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 284 | 0.640 |
Why?
|
| Cell-Derived Microparticles | 2 | 2020 | 10 | 0.620 |
Why?
|
| Repressor Proteins | 1 | 2019 | 114 | 0.600 |
Why?
|
| Reactive Oxygen Species | 3 | 2015 | 277 | 0.600 |
Why?
|
| Ovarian Neoplasms | 3 | 2013 | 563 | 0.600 |
Why?
|
| Cell Communication | 2 | 2020 | 66 | 0.590 |
Why?
|
| 3' Untranslated Regions | 2 | 2015 | 33 | 0.590 |
Why?
|
| Cell Survival | 7 | 2019 | 392 | 0.570 |
Why?
|
| Blotting, Western | 6 | 2021 | 503 | 0.560 |
Why?
|
| Female | 13 | 2021 | 14433 | 0.540 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein D | 1 | 2015 | 3 | 0.500 |
Why?
|
| Mice, Nude | 4 | 2021 | 312 | 0.500 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 54 | 0.480 |
Why?
|
| Chloroquine | 1 | 2014 | 8 | 0.480 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 93 | 0.480 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 104 | 0.470 |
Why?
|
| Animals | 11 | 2021 | 9934 | 0.470 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2014 | 4 | 0.460 |
Why?
|
| Peroxiredoxin VI | 1 | 2014 | 1 | 0.460 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2014 | 31 | 0.460 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 106 | 0.450 |
Why?
|
| RNA, Neoplasm | 1 | 2013 | 24 | 0.440 |
Why?
|
| Thromboplastin | 2 | 2010 | 28 | 0.430 |
Why?
|
| Wnt Proteins | 1 | 2013 | 32 | 0.430 |
Why?
|
| Skin | 1 | 2014 | 140 | 0.420 |
Why?
|
| Ionophores | 2 | 2009 | 6 | 0.410 |
Why?
|
| Receptors, Gastrointestinal Hormone | 2 | 2002 | 3 | 0.410 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 57 | 0.400 |
Why?
|
| Nitroquinolines | 1 | 2011 | 2 | 0.390 |
Why?
|
| Cell Line | 4 | 2019 | 671 | 0.370 |
Why?
|
| Acetylcysteine | 1 | 2010 | 24 | 0.360 |
Why?
|
| Copper | 1 | 2010 | 43 | 0.350 |
Why?
|
| Glutathione Peroxidase | 2 | 2007 | 16 | 0.350 |
Why?
|
| Nucleotide Motifs | 2 | 2020 | 20 | 0.350 |
Why?
|
| Hydrogen Peroxide | 1 | 2010 | 138 | 0.340 |
Why?
|
| Metals | 1 | 2009 | 39 | 0.340 |
Why?
|
| Transcription, Genetic | 2 | 2009 | 398 | 0.340 |
Why?
|
| Superoxide Dismutase-1 | 4 | 2015 | 45 | 0.330 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 47 | 0.320 |
Why?
|
| CRISPR-Cas Systems | 2 | 2019 | 43 | 0.320 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2019 | 250 | 0.320 |
Why?
|
| Base Sequence | 3 | 2020 | 573 | 0.310 |
Why?
|
| Lipid Peroxidation | 4 | 2014 | 47 | 0.310 |
Why?
|
| Down-Regulation | 2 | 2004 | 196 | 0.280 |
Why?
|
| Disease Progression | 2 | 2018 | 450 | 0.270 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 624 | 0.270 |
Why?
|
| Cyclic AMP | 2 | 2003 | 80 | 0.260 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 748 | 0.250 |
Why?
|
| Neoplasm Invasiveness | 2 | 2018 | 180 | 0.240 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 322 | 0.240 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 1925 | 0.230 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2015 | 80 | 0.220 |
Why?
|
| Colforsin | 1 | 2003 | 12 | 0.220 |
Why?
|
| Islets of Langerhans | 1 | 2003 | 9 | 0.210 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2015 | 175 | 0.210 |
Why?
|
| Mice | 4 | 2021 | 4394 | 0.210 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 33 | 0.210 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 364 | 0.210 |
Why?
|
| Biological Transport | 2 | 2015 | 107 | 0.200 |
Why?
|
| Gastrinoma | 1 | 2002 | 3 | 0.200 |
Why?
|
| Receptors, Cholecystokinin | 1 | 2002 | 5 | 0.200 |
Why?
|
| RNA Splicing | 1 | 2002 | 9 | 0.200 |
Why?
|
| Introns | 1 | 2002 | 41 | 0.200 |
Why?
|
| Microscopy, Electron | 1 | 2021 | 94 | 0.200 |
Why?
|
| Circulating MicroRNA | 1 | 2021 | 10 | 0.200 |
Why?
|
| Tumor Cells, Cultured | 4 | 2004 | 310 | 0.190 |
Why?
|
| Endothelial Cells | 2 | 2015 | 333 | 0.190 |
Why?
|
| Insulin | 1 | 2003 | 309 | 0.190 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2002 | 125 | 0.190 |
Why?
|
| Ribonucleoproteins | 1 | 2002 | 150 | 0.180 |
Why?
|
| Gene Expression | 2 | 2002 | 405 | 0.180 |
Why?
|
| Microscopy, Fluorescence | 2 | 2013 | 161 | 0.180 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 245 | 0.170 |
Why?
|
| Protein Transport | 2 | 2015 | 152 | 0.170 |
Why?
|
| Fish Oils | 1 | 2019 | 9 | 0.170 |
Why?
|
| Aged | 2 | 2021 | 5158 | 0.170 |
Why?
|
| MCF-7 Cells | 1 | 2019 | 33 | 0.170 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 35 | 0.170 |
Why?
|
| RNA, Nuclear | 1 | 2019 | 4 | 0.170 |
Why?
|
| Gene Ontology | 1 | 2019 | 12 | 0.160 |
Why?
|
| Tamoxifen | 1 | 2019 | 30 | 0.160 |
Why?
|
| Cell Hypoxia | 1 | 2019 | 35 | 0.160 |
Why?
|
| Green Fluorescent Proteins | 1 | 2019 | 100 | 0.160 |
Why?
|
| Protein Binding | 1 | 2020 | 631 | 0.160 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2011 | 101 | 0.160 |
Why?
|
| Genes, jun | 1 | 1998 | 3 | 0.160 |
Why?
|
| DNA Primers | 2 | 2013 | 143 | 0.160 |
Why?
|
| Trans-Activators | 1 | 2019 | 113 | 0.150 |
Why?
|
| Receptors, Muscarinic | 1 | 1998 | 9 | 0.150 |
Why?
|
| Genes, fos | 1 | 1998 | 13 | 0.150 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 194 | 0.150 |
Why?
|
| Transduction, Genetic | 1 | 1998 | 24 | 0.150 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 216 | 0.150 |
Why?
|
| Caspase 3 | 2 | 2010 | 56 | 0.150 |
Why?
|
| Middle Aged | 2 | 2021 | 6808 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 332 | 0.150 |
Why?
|
| Drug Synergism | 2 | 2009 | 100 | 0.150 |
Why?
|
| Chelating Agents | 2 | 2009 | 21 | 0.150 |
Why?
|
| Cell Movement | 1 | 2019 | 352 | 0.150 |
Why?
|
| Dietary Supplements | 1 | 2019 | 212 | 0.140 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 31 | 0.140 |
Why?
|
| Heterografts | 1 | 2016 | 62 | 0.140 |
Why?
|
| Nanoparticles | 1 | 2020 | 273 | 0.140 |
Why?
|
| NF-kappa B | 2 | 2008 | 187 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2008 | 146 | 0.140 |
Why?
|
| Neoplasm Grading | 1 | 2016 | 104 | 0.140 |
Why?
|
| ROC Curve | 1 | 2016 | 137 | 0.130 |
Why?
|
| Prognosis | 1 | 2018 | 758 | 0.130 |
Why?
|
| Cell Proliferation | 1 | 2019 | 765 | 0.130 |
Why?
|
| Catalase | 2 | 2007 | 48 | 0.130 |
Why?
|
| RNA, Messenger | 3 | 2002 | 644 | 0.130 |
Why?
|
| rab27 GTP-Binding Proteins | 1 | 2015 | 5 | 0.130 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 456 | 0.120 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2015 | 33 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 131 | 0.120 |
Why?
|
| Case-Control Studies | 1 | 2016 | 699 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 123 | 0.120 |
Why?
|
| Fluorescent Dyes | 1 | 2014 | 87 | 0.120 |
Why?
|
| Antioxidant Response Elements | 1 | 2014 | 5 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 437 | 0.120 |
Why?
|
| Radiation, Ionizing | 1 | 2014 | 25 | 0.110 |
Why?
|
| Radiation Tolerance | 1 | 2014 | 29 | 0.110 |
Why?
|
| Phosphorylation | 1 | 2015 | 557 | 0.110 |
Why?
|
| Genes, Reporter | 1 | 2013 | 88 | 0.110 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 118 | 0.100 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2012 | 11 | 0.100 |
Why?
|
| Transcriptome | 1 | 2014 | 198 | 0.100 |
Why?
|
| Alternative Splicing | 2 | 2002 | 44 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2013 | 143 | 0.100 |
Why?
|
| Cloning, Molecular | 2 | 2002 | 204 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2002 | 77 | 0.100 |
Why?
|
| HL-60 Cells | 1 | 2011 | 22 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 587 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 1392 | 0.090 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2010 | 22 | 0.090 |
Why?
|
| Rats | 1 | 2014 | 1535 | 0.090 |
Why?
|
| Amino Acid Sequence | 2 | 2002 | 673 | 0.090 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 110 | 0.090 |
Why?
|
| Molecular Sequence Data | 2 | 2002 | 1034 | 0.090 |
Why?
|
| Protease Inhibitors | 1 | 2009 | 40 | 0.080 |
Why?
|
| Clofibrate | 1 | 2009 | 4 | 0.080 |
Why?
|
| Cathepsin D | 1 | 2009 | 3 | 0.080 |
Why?
|
| Ammonium Chloride | 1 | 2009 | 4 | 0.080 |
Why?
|
| Intracellular Membranes | 1 | 2009 | 15 | 0.080 |
Why?
|
| Thiones | 1 | 2009 | 55 | 0.080 |
Why?
|
| Pyridines | 1 | 2009 | 99 | 0.080 |
Why?
|
| Cell Membrane Permeability | 1 | 2009 | 42 | 0.080 |
Why?
|
| Ligands | 1 | 2009 | 168 | 0.080 |
Why?
|
| Triazenes | 1 | 2008 | 2 | 0.080 |
Why?
|
| Ethylenediamines | 1 | 2008 | 2 | 0.080 |
Why?
|
| Mutation | 1 | 2012 | 818 | 0.080 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2007 | 35 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2007 | 209 | 0.070 |
Why?
|
| Vitamin E | 1 | 2006 | 11 | 0.070 |
Why?
|
| Transcription Factor RelA | 1 | 2006 | 21 | 0.070 |
Why?
|
| Cisplatin | 1 | 2007 | 172 | 0.070 |
Why?
|
| Male | 1 | 2021 | 12845 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 67 | 0.070 |
Why?
|
| Mitochondria | 1 | 2009 | 324 | 0.060 |
Why?
|
| Coagulants | 1 | 2005 | 7 | 0.060 |
Why?
|
| Annexin A5 | 1 | 2005 | 24 | 0.060 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 18 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2005 | 283 | 0.060 |
Why?
|
| Caspases | 1 | 2005 | 42 | 0.060 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2004 | 5 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 228 | 0.060 |
Why?
|
| Blood Coagulation | 1 | 2005 | 116 | 0.060 |
Why?
|
| Cattle | 1 | 2005 | 383 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2005 | 293 | 0.050 |
Why?
|
| Flavonoids | 1 | 2003 | 31 | 0.050 |
Why?
|
| Secretin | 1 | 2002 | 2 | 0.050 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2002 | 5 | 0.050 |
Why?
|
| COS Cells | 1 | 2002 | 48 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 83 | 0.050 |
Why?
|
| Dimerization | 1 | 2002 | 75 | 0.050 |
Why?
|
| CHO Cells | 1 | 2002 | 96 | 0.050 |
Why?
|
| Cricetinae | 1 | 2002 | 129 | 0.050 |
Why?
|
| Cell Division | 1 | 2002 | 153 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2002 | 117 | 0.050 |
Why?
|
| Splicing Factor U2AF | 1 | 2002 | 1 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2003 | 93 | 0.050 |
Why?
|
| Receptor, Cholecystokinin B | 1 | 2002 | 8 | 0.050 |
Why?
|
| Exons | 1 | 2002 | 41 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2002 | 76 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 247 | 0.050 |
Why?
|
| Transfection | 1 | 2002 | 312 | 0.050 |
Why?
|
| Muscarine | 1 | 1998 | 1 | 0.040 |
Why?
|
| Genes, Immediate-Early | 1 | 1998 | 5 | 0.040 |
Why?
|
| Muscarinic Agonists | 1 | 1998 | 9 | 0.040 |
Why?
|
| Carbachol | 1 | 1998 | 18 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 31 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 1998 | 72 | 0.040 |
Why?
|
| Calcium | 1 | 1998 | 231 | 0.040 |
Why?
|
| Adult | 1 | 2002 | 7370 | 0.020 |
Why?
|
| Factor VIIIa | 1 | 2005 | 2 | 0.020 |
Why?
|
| Factor X | 1 | 2005 | 11 | 0.020 |
Why?
|
| Phosphatidylserines | 1 | 2005 | 20 | 0.020 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2005 | 35 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2005 | 58 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 144 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2005 | 259 | 0.010 |
Why?
|